Skip to main content
SNDX $8.72 -4.49%
SNDX logo
SNDX · Syndax Pharmaceuticals Inc
Track SNDX — free
$8.72 -0.41 (-4.49%) At close · Nov 20 Play latest call Q2 2026 earnings call transcript
Market Cap
$778.67M
Shares
89.30M
Volume · Nov 20 2.18M Avg daily vol (3M) 2.61M
All webcasts

Earnings call · FY2026 Q1

Syndax Pharmaceuticals Inc (SNDX) Q1 2026 Earnings Call

Concluded Apr 30, 2026
Apr 30, 2026
Period
FY2026 Q1
Runtime
—
Sources
2 artifacts
Revenue $64.86M +223.6% YoY
Diluted EPS -$0.48
Net income -$42.67M
Open full screen 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Forward guidance

3 guided metrics

Management's latest ranges and targets are included below.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Forward guidance

From the 8-K filed Apr 30, 2026.

Metric Guided
Total research and development plus selling, general and adminis Maintained
full year of 2026
$400M
Non-cash stock compensation expense
full year of 2026
$50M
R&D + SG&A expense Maintained
2026
$400M

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Product$48.92M +144.1% YoY
Collaboration Revenue$15.94M
Full-screen source Call document